Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
3.
Ann Clin Psychiatry ; 8(1): 11-7, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8743643

ABSTRACT

In view of recent trends toward the replacement of traditional inpatient rehabilitation programs with nonresidential services, we examined the extent to which patients currently admitted to inpatient rehabilitation for alcohol or drug abuse/dependence met published criteria suggesting a preferential need for inpatient or residential care. Over 90% of almost 300 veterans with a primary DSM-III R diagnosis of alcohol or substance abuse/dependence, admitted to six New York Metropolitan Area Veterans Administration Medical Centers for inpatient rehabilitation, met at least one criterion dimension considered indicative of a need for such services, with over two-thirds meeting two or more dimensions. These findings suggest a continuing need for initial primary inpatient or residential rehabilitation for such patients.


Subject(s)
Managed Care Programs/standards , Patient Admission/standards , Patient Selection , Substance-Related Disorders/rehabilitation , Adult , Alcoholism/economics , Alcoholism/rehabilitation , Chi-Square Distribution , Cognition Disorders/rehabilitation , Health Services Needs and Demand , Hospitals, Veterans/statistics & numerical data , Humans , Male , New Jersey , New York , Patient Admission/economics , Patient Admission/statistics & numerical data , Severity of Illness Index , Substance-Related Disorders/economics , Veterans/statistics & numerical data
4.
Neuropsychopharmacology ; 9(1): 49-53, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8397723

ABSTRACT

Thirty patients with primary cocaine dependence who had used cocaine within the past 24 hours and were being admitted to a detoxification ward were rated for signs and symptoms of cocaine abstinence and craving. They then received four doses of either L-dihydroxy-phenylalanine/carbidopa (100 mg/25 mg) or placebo over the next day. Ratings were repeated in the late afternoon of the day of admission and after the final morning dose the next day. No significant differences in abstinence scores were found between the two treatment groups. The lack of drug-placebo differences appeared to be mainly due to rapid clearing of abstinence symptoms in the placebo-treated patients.


Subject(s)
Carbidopa/therapeutic use , Cocaine , Levodopa/therapeutic use , Substance Withdrawal Syndrome/drug therapy , Adult , Breath Tests , Drug Combinations , Electrocardiography/drug effects , Humans , Substance Withdrawal Syndrome/psychology
6.
J Am Dent Assoc ; 117(6): 698, 1988 Nov.
Article in English | MEDLINE | ID: mdl-3198877
SELECTION OF CITATIONS
SEARCH DETAIL
...